References
1.Shapiro D, Harel M, Ferrer F, McKenna PH. Focusing on organ
preservation and function: paradigm shifts in the treatment of pediatric
genitourinary rhabdomyosarcoma. Int Urol Nephrol 2016; 48: 1009-1113.
2.Soler R, Jr Macedo A, Bruschini H, Puty F, Caran E, Petrilli A,
Garrone G, Srougi M, Ortiz V. Does the less aggressive multimodal
approach of treating bladder-prostate rhabdomyosarcoma preserve bladder
function? J Urol 2005; 174: 2343-6.
3.Yeung CK, Ward HC, Ransley PG, Duffy PG, Pritchard J. Bladder and
kidney function after cure of pelvic rhabdomyosarcoma in childhood. Br J
Cancer 1994; 70: 1000–1003.
4. Raney B, Heyn R, Hays DM, Tefft M, Newton WA, Wharam M,
Vassilopoulou-Sellin R, Maurer HM. Sequelae of treatment in 109 patients
followed for 5 to 15 years after diagnosis of sarcoma of the bladder
and prostate. A report from the Intergroup Rhabdomyosarcoma Study
Committee. Cancer 1993, 71: 2387–2394.
5. Hays DM, Raney RB, Wharam MD, Wiener E, Lobe TE, Andrassy RJ,
Lawrence W, Johnston J, Webber B, Maurer HM. Children with vesical
rhabdomyosarcoma (RMS) treated by partial cystectomy with neoadjuvant or
adjuvant chemotherapy, with or without radiotherapy. A report from the
Intergroup Rhabdomyosarcoma Study (IRS) Committee. J Pediatr Hematol
Oncol 1995; 17: 46–52.
6. Martelli H, Haie-Meder C, Branchereau S, Franchi-Abella S, Ghigna M,
Dumas I, Bouvet N, Oberlin O. Conservative surgery plus brachytherapy
treatment for boys with prostate and/or bladder neck rhabdomyosarcoma: a
single team experience. J Pediat Surg 2009; 44:190–196.
7. Chargari C, Haie-Meder C, Guérin F, Minard-Colin V, lambert G,
Mazeron R, Escande A, Marsolat F, Dumas I, Deutsch E, Valteau-Couanet D,
Audry G, Oberlin O, Martelli H. Brachytherapy Combined With Surgery for
Conservative Treatment of Children With Bladder Neck and/or Prostate
Rhabdomyosarcoma. Int J Radiat Onc Biol Phys 2017; 98: 352–359.
8. Fuchs J, Paulsen F, Bleif M, Lamprecht U, Weidner N, Zips D,
Neunhoeffer F, Seitz G. Conservative surgery with combined high dose
rate brachytherapy for patients suffering from genitourinary and
perianal rhabdomyosarcoma. Radiother Oncol 2016; 212: 262-7.
9. Nag S, Tippin D, Ruymann F. Long-term morbidity in children treated
with fractionated high-dose-rate brachytherapy for soft tissue sarcomas.
J Pediatr Hematol Oncol 2003; 25: 448-452.
10. Viani G, Novaes P, Jacinto A, Antonelli CB, Pellizon AC, Saito EY,
Salvajoli J. High-dose brachyterapy for soft tissue sarcoma in children:
a single institution experience. Radiat Oncol 2008, 3:9.
11. Chargari C, Martelli H, Guerin F, Bacorro W, Lambert G, Escande A,
Minar-Colin V, Dumas I, Deutsch E, Haie-Meder C. Pulsed-dose rate
brachytherapy for pediatric bladder prostate rhabdomyosarcoma:
compliance and early clinical results. Radiother Oncol 2017; 124:285-90.
12. Ep SSG RMS 2005 - a Protocol for non metastatic
rhabdomyosarcoma,
https://www.skion.nl/workspace/uploads/Protocol-EpSSG-RMS-2005-1-3-May-2012_1.pdf.
13. Hoskin PJ, Colombo A, Henry A, Niehoff P, Hellebust TP, Siebert F,
Kovacs G. GEC/ESTRO recommendations on high dose rate afterloading
brachytherapy for localised prostate cancer: An update. Radiother Oncol
2013; 107:325–32.
14. Pötter R, Tanderup K, Kirisits C, et al. The EMBRACE II
study: The outcome and prospect of two decades of evolution within the
GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl Radiat
Oncol 2018; 9:48–60.
15. Leeuwen CM, Oei AL, Crezee J,Bel A, Franken NAP, Stalpers LJA, Kok
HP. The alfa and beta of tumours: a review of parameters of the
linear-quadratic model, derived from clinical radiotherapy studies.
Radiat Oncol 2018;13:96.
16. Rivard MJ, Coursey BM, DeWerd LA, et al. Update of AAPM Task Group
No. 43 Report: A revised AAPM protocol for brachytherapy dose
calculations. Med Phys 2004;31:633–74.
17. Hjälmås K. Urodynamics in normal infants and children. Scand J Urol
Nephrol 1988; S114: 20–7.
18. Holmdahl G, Hanson E, Hansom M, Hellström AL, Hjälmås K, Sillén U.
Four-hour voiding observation in healthy infants. J Urol
1996;156:1809–12.
19. Rodeberg DA, Anderson JR, Arndt CA, Ferrer FA, et al. Comparison of
outcomes based on treatment algorithms for rhabdomyosarcoma of the
bladder/prostate: combined results from the Children’s Oncology Group,
German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group,
and International Society of Pediatric Oncology Malignant Mesenchymal
Tumours Committee, Int J Cancer 2011; 128:1232–1239.
20. Schimdt A, Warmann S, Eckert F, Ellerkamp V, Schaefer J, Blumenstock
G, Paulsen F, Fuchs J. The Role of Reconstructive surgery and
brachytherapy in pediatric Bladder/prostate rhabdomyosarcoma, J Urol
2020; 204: 826-834.